Conference Coverage AHA 2017 See All Content See past conferences Anaheim, CA November 11, 2017 November 15, 2017 News Conference News Long-Awaited Hypertension Guidelines Released at AHA (UPDATED) The treatment goal has been lowered, and a new classification expands the number of US adults considered to have hypertension. < > Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017 Big BP Reductions When DASH Diet Combined With Low Sodium Intake Michael O'Riordan November 12, 2017 AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More Shelley Wood November 09, 2017 News News Conference News Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality Michael O'Riordan November 14, 2017 News Conference News Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery Shelley Wood November 14, 2017 News Conference News GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS Yael L. Maxwell November 14, 2017 News Conference News Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017 News Conference News More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017 Slides Presentation Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial Presenter: Steven Weisbord November 13, 2017 Presentation Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial Presenter: Akihiko Nogami November 13, 2017 Presentation Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes Presenter: Louise Bowman November 14, 2017 Presentation Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality Presenter: Mar Pujades-Rodriguez November 14, 2017 AHA 2017 Wrap-Up Interview: Yael L. Maxwell interviews Dr. David Cohen See More Videos @TCTMD Follow Us
News Conference News Long-Awaited Hypertension Guidelines Released at AHA (UPDATED) The treatment goal has been lowered, and a new classification expands the number of US adults considered to have hypertension.
Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More Shelley Wood November 09, 2017
News Conference News Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality Michael O'Riordan November 14, 2017
News Conference News Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery Shelley Wood November 14, 2017
News Conference News GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS Yael L. Maxwell November 14, 2017
News Conference News Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Conference News More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017
Presentation Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial Presenter: Steven Weisbord November 13, 2017
Presentation Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial Presenter: Akihiko Nogami November 13, 2017
Presentation Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes Presenter: Louise Bowman November 14, 2017
Presentation Time at Blood Pressure Target and the Risk of Cardiovascular Diseases and Mortality Presenter: Mar Pujades-Rodriguez November 14, 2017